149 noterade bolag på Stockholmsbörsen.
| Bolag | Börsvärde |
|---|---|
| Oncopeptides AB Stockholm | 524 mkr |
| Nanoform Finland Oyj | 511 mkr |
| Moberg Pharma AB BROMMA | 474 mkr |
| Corline Biomedical AB UPPSALA | 411 mkr |
| Q-linea AB UPPSALA | 410 mkr |
| OssDsign AB UPPSALA | 387 mkr |
| Sprint Bioscience AB HUDDINGE | 386 mkr |
| Ascelia Pharma AB MALMÖ | 377 mkr |
| Mentice AB GÖTEBORG | 374 mkr |
| BIO-WORKS TECHNOLOGIES AB UPPSALA | 344 mkr |
| Acarix AB MALMÖ | 331 mkr |
| SciBase Holding AB STOCKHOLM | 311 mkr |
| Mendus AB Mölndal | 306 mkr |
| Klaria Pharma Holding AB UPPSALA | 300 mkr |
| Intervacc AB HÄGERSTEN | 286 mkr |
| Elicera Therapeutics AB GÖTEBORG | 274 mkr |
| Promimic AB MÖLNDAL | 259 mkr |
| BrainCool AB LUND | 253 mkr |
| Xintela AB LUND | 245 mkr |
| Initiator Pharma A/S | 224 mkr |
| Medclair AB SKARPNÄCK | 214 mkr |
| Prolight Diagnostics AB LUND | 212 mkr |
| Diamyd Medical AB Class B STOCKHOLM | 197 mkr |
| Isofol Medical AB Göteborg | 193 mkr |
| Integrum AB Class B MÖLNDAL | 189 mkr |
| DEXTECH MEDICAL AB UPPSALA | 187 mkr |
| MICROPOS MEDICAL AB GÖTEBORG | 182 mkr |
| Episurf Medical AB Class B STOCKHOLM | 171 mkr |
| AlzeCure Pharma AB HUDDINGE | 169 mkr |
| SenzaGen AB LUND | 168 mkr |
| Active Biotech AB LUND | 161 mkr |
| Clinical Laserthermia Systems AB Class B LUND | 155 mkr |
| ACUCORT AB LUND | 155 mkr |
| NextCell Pharma AB HUDDINGE | 153 mkr |
| Xbrane Biopharma AB SOLNA | 153 mkr |
| Boule Diagnostics AB SPÅNGA | 151 mkr |
| Immunovia AB STOCKHOLM | 143 mkr |
| Scandinavian Real Heart AB VÄSTERÅS | 138 mkr |
| IRLAB Therapeutics AB Class A GÖTEBORG | 133 mkr |
| Simris Group AB Class B HAMMENHÖG | 129 mkr |
| ABERA BIOSCIENCE AB UPPSALA | 125 mkr |
| Bioextrax AB LUND | 119 mkr |
| Arcoma AB Växjö | 119 mkr |
| Nanologica AB SÖDERTÄLJE | 119 mkr |
| New Nordic Healthbrands AB MALMÖ | 115 mkr |
| Biovica International AB Class B UPPSALA | 111 mkr |
| Glycorex Transplantation AB Class B LUND | 98 mkr |
| Scandinavian ChemoTech AB Class B LUND | 98 mkr |
| Annexin Pharmaceuticals AB STOCKHOLM | 97 mkr |
| Alligator Bioscience AB LUND | 96 mkr |